Perceptive's 1.99M-Share, 7.3% Holding in Alto Neuroscience Disclosed
Rhea-AI Filing Summary
Perceptive Advisors LLC, Perceptive Life Sciences Master Fund, Ltd. and Joseph Edelman disclosed a 7.3% beneficial ownership stake in Alto Neuroscience, Inc. (ticker ANRO), representing 1,989,393 shares of common stock. The filing states the ownership percentage is calculated from 27,076,629 outstanding shares as of August 8, 2025. The Master Fund directly holds the shares while Perceptive Advisors acts as investment manager and Mr. Edelman is the managing member, so each reporting person reports shared voting and dispositive power over the same block. The filing certifies the position is not held to change or influence control of the issuer.
Positive
- Material disclosure: Reporting of a 7.3% stake ensures regulatory transparency for investors
- Single-block ownership: All reporting persons disclose the same 1,989,393 shares, reducing ambiguity about overlapping claims
Negative
- No sole voting or dispositive power reported, indicating limited unilateral influence over corporate decisions
- 7.3% stake may still exert market influence without a control intent, creating potential activist interest or trading volatility
Insights
Perceptive reports a material >5% passive stake and shared control of 1.99M shares.
The reported 1,989,393 shares equal 7.3% of the outstanding common stock based on 27,076,629 shares as of August 8, 2025, which meets the disclosure threshold requiring a Schedule 13G.
This position is described as shared voting and dispositive power and certified as not acquired to change control, indicating a likely passive or investment-management holding. Investors should note the holding is large enough to be a visible institutional stake but the filers disclaim a control intent in the near term.
FAQ
What stake did Perceptive report in Alto Neuroscience (ANRO)?
How was the 7.3% ownership percentage calculated?
Does the filing indicate Perceptive seeks control of ANRO?
Who holds voting and disposal power for the reported shares?
When was the Schedule 13G signed?